These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6366276)

  • 1. Imipramine treatment of painful diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    JAMA; 1984 Apr; 251(13):1727-30. PubMed ID: 6366276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imipramine in the treatment of painful diabetic neuropathy of the extremities].
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Ugeskr Laeger; 1983 Sep; 145(39):3018-9. PubMed ID: 6359618
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of effect of mianserin on the symptoms of diabetic neuropathy.
    Sindrup SH; Tuxen C; Gram LF; Grodum E; Skjold T; Brøsen K; Beck-Nielsen H
    Eur J Clin Pharmacol; 1992; 43(3):251-5. PubMed ID: 1425887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressive agents in the treatment of diabetic neuropathy.
    Kvinesdal B; Molin J; Frøland A; Gram LF
    Clin Physiol; 1985; 5 Suppl 5():97-100. PubMed ID: 3914393
    [No Abstract]   [Full Text] [Related]  

  • 5. Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs.
    Young RJ; Clarke BF
    Diabet Med; 1985 Sep; 2(5):363-6. PubMed ID: 2435449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function.
    Sindrup SH; Ejlertsen B; Frøland A; Sindrup EH; Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):151-3. PubMed ID: 2792168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Brøsen K; Eshøj O; Mogensen EF
    Pain; 1990 Aug; 42(2):135-144. PubMed ID: 2147235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
    Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
    N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Skjold T; Frøland A; Beck-Nielsen H
    Clin Pharmacol Ther; 1990 Apr; 47(4):509-15. PubMed ID: 2328559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression masquerading as diabetic neuropathy.
    Turkington RW
    JAMA; 1980 Mar; 243(11):1147-50. PubMed ID: 6987418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma beta-endorphin is not affected by treatment with imipramine or paroxetine in patients with diabetic neuropathy symptoms.
    Sindrup SH; Bach FW; Gram LF
    Clin J Pain; 1992 Jun; 8(2):145-8. PubMed ID: 1385995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.
    Shaibani A; Fares S; Selam JL; Arslanian A; Simpson J; Sen D; Bongardt S
    J Pain; 2009 Aug; 10(8):818-28. PubMed ID: 19409861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.
    Max MB; Kishore-Kumar R; Schafer SC; Meister B; Gracely RH; Smoller B; Dubner R
    Pain; 1991 Apr; 45(1):3-9. PubMed ID: 1861872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy.
    Mendel CM; Klein RF; Chappell DA; Dere WH; Gertz BJ; Karam JH; Lavin TN; Grunfeld C
    JAMA; 1986 Feb; 255(5):637-9. PubMed ID: 3511312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of painful diabetic neuropathy with capsaicin 0.075%.
    Scheffler NM; Sheitel PL; Lipton MN
    J Am Podiatr Med Assoc; 1991 Jun; 81(6):288-93. PubMed ID: 1920093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.
    Sindrup SH; Gram LF; Skjold T; Grodum E; Brøsen K; Beck-Nielsen H
    Br J Clin Pharmacol; 1990 Nov; 30(5):683-91. PubMed ID: 2271367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy.
    Chadda VS; Mathur MS
    J Assoc Physicians India; 1978 May; 26(5):403-6. PubMed ID: 365857
    [No Abstract]   [Full Text] [Related]  

  • 20. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
    Kulkantrakorn K; Lorsuwansiri C; Meesawatsom P
    Pain Pract; 2013 Jul; 13(6):497-503. PubMed ID: 23228119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.